Amneal Pharmaceuticals (AMRX) Operating Margin (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Operating Margin of 19.62% for Q1 2026, up 519.0% year-over-year from 3.17% in Q1 2025, and up 42.62% quarter-over-quarter from 13.76% in Q4 2025.
Amneal Pharmaceuticals (AMRX) Operating Margin (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Operating Margin history runs 10 years deep, the most recent figure standing at 19.62% for Q1 2026.
- In Q1 2026, Operating Margin rose 519.0% year-over-year to 19.62%; the TTM figure through Mar 2026 stood at 14.3% (up 156.0% YoY), while the FY2025 annual figure was 13.05%, up 413.0% from the prior year.
- Operating Margin for Q1 2026 stood at 19.62%, up from 13.76% in the prior quarter.
- The five-year high for Operating Margin was 19.62% in Q1 2026, with the low at 35.51% in Q2 2022.
- The 5-year median for Operating Margin is 10.38% (2024), against an average of 6.18%.
- The sharpest annual moves came in 2022 and 2023: Operating Margin plunged 4805 bps in 2022, then surged 4888 bps in 2023.
- Amneal Pharmaceuticals' Operating Margin stood at 8.72% in 2022, then soared by 126 bps to 2.3% in 2023, then surged by 351 bps to 10.38% in 2024, then soared by 33 bps to 13.76% in 2025, then soared by 43 bps to 19.62% in 2026.
- Business Quant data shows AMRX's Operating Margin at 19.62% in Q1 2026, 13.76% in Q4 2025, and 8.97% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 16.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.30% |
| Mar 31, 2026 | 19.62% |
| Dec 31, 2025 | 13.76% |
| Sep 30, 2025 | 8.97% |
| Jun 30, 2025 | 15.37% |
| Mar 31, 2025 | 14.43% |
| Dec 31, 2024 | 10.38% |
| Sep 30, 2024 | 12.64% |
| Jun 30, 2024 | 13.60% |
| Mar 31, 2024 | -1.63% |
| Dec 31, 2023 | 2.30% |
| Sep 30, 2023 | 12.20% |
| Jun 30, 2023 | 13.37% |
| Mar 31, 2023 | 6.18% |
| Dec 31, 2022 | -8.72% |
| Sep 30, 2022 | 8.13% |
| Jun 30, 2022 | -35.51% |
| Mar 31, 2022 | 0.02% |
| Dec 31, 2021 | 2.08% |
| Sep 30, 2021 | 5.39% |